Sang-Jun Ha
Overview
Explore the profile of Sang-Jun Ha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
5630
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Song Y, Na H, Lee S, Kim Y, Moon J, Nam T, et al.
Nat Commun
. 2024 Jul;
15(1):5623.
PMID: 38965229
No abstract available.
12.
Cha J, Kim D, Kim G, Cho J, Sung E, Baek S, et al.
J Immunother Cancer
. 2024 Jun;
12(6).
PMID: 38857913
Background: Oropharyngeal squamous cell carcinoma (OPSCC) induced by human papillomavirus (HPV-positive) is associated with better clinical outcomes than HPV-negative OPSCC. However, the clinical benefits of immunotherapy in patients with HPV-positive...
13.
Song Y, Na H, Lee S, Kim Y, Moon J, Nam T, et al.
Nat Commun
. 2024 May;
15(1):4052.
PMID: 38744820
Obesity has emerged as a prominent risk factor for the development of malignant tumors. However, the existing literature on the role of adipocytes in the tumor microenvironment (TME) to elucidate...
14.
Park J, Zhang H, Kwak H, Gadhe C, Kim Y, Kim H, et al.
Front Pharmacol
. 2023 Nov;
14:1275749.
PMID: 38035024
Inhibition of angiogenesis is considered a promising therapeutic approach for cancer treatment. Our previous genetic research showed that the use of a cell-penetrating peptide to inhibit the pleckstrin homology (PH)...
15.
Lee H, Jung M, Noh J, Park S, Chung Y, Ha S, et al.
Nat Immunol
. 2023 Sep;
24(11):1794-1796.
PMID: 37770795
No abstract available.
16.
Seok J, Cho S, Lee J, Choi Y, Kim S, Lee S, et al.
Nat Immunol
. 2023 Jun;
24(8):1308-1317.
PMID: 37365384
Virtual memory T (T) cells are a T cell subtype with a memory phenotype but no prior exposure to foreign antigen. Although T cells have antiviral and antibacterial functions, whether...
17.
Kang M, Hong J, Lee J, Cha M, Lee S, Kim H, et al.
Cell Mol Immunol
. 2023 May;
20(7):820-834.
PMID: 37246159
Recombinant interleukin-33 (IL-33) inhibits tumor growth, but the detailed immunological mechanism is still unknown. IL-33-mediated tumor suppression did not occur in Batf3 mice, indicating that conventional type 1 dendritic cells...
18.
Kwon K, Kang T, Lee A, Jin S, Lim Y, Shin S, et al.
Immune Netw
. 2023 May;
23(2):e16.
PMID: 37179749
Bacillus Calmette-Guerin (BCG) vaccine is the only licensed vaccine for tuberculosis (TB) prevention. Previously, our group demonstrated the vaccine potential of Rv0351 and Rv3628 against (Mtb) infection by directing Th1-biased...
19.
Yoo S, Jeong Y, Choi H, Chae S, Hwang D, Shin S, et al.
Exp Mol Med
. 2023 Apr;
55(5):999-1012.
PMID: 37121977
Chronic viral infection impairs systemic immunity in the host; however, the mechanism underlying the dysfunction of immune cells in chronic viral infection is incompletely understood. In this study, we studied...
20.
Kim M, Kim K, Park H, Kim G, Hong K, Oh J, et al.
Nat Immunol
. 2022 Dec;
24(1):148-161.
PMID: 36577929
Regulatory T (T) cells have an immunosuppressive function and highly express the immune checkpoint receptor PD-1 in the tumor microenvironment; however, the function of PD-1 in tumor-infiltrating (TI) T cells...